Homepage > Catalog > Business economics - Miscellaneous

Do Pharmaceutical Mergers Harm Drug Innovation?

Name: Do Pharmaceutical Mergers Harm Drug Innovation?
Price: 27.95 EUR
Availability: InStock
Author: Jan Schmidt
ISBN: 978-3-656-96217-5

Master's Thesis, 2013

49 Pages, Grade: 8,5 (NL, äquivalent zu 1,2)

Jan Schmidt (Author)

Excerpt

Tables and Figures

Introduction

1. Theoretical Framework and industry
1.1. Overview of M&A Theory and the pharmaceutical industry
1.2. Review of R&D and the drug approval process

2. Empirical Analyses
2.1. Empirical specification and data
2.1.1. Empirical specification
2.1.2. Data
2.2. Results - Mergers & Acquisitions and R&D intensity
2.3. Mergers & Acquisitions and R&D efficiency

3. Small Acquisitions and their Impact on Industry Efficiency

4. Discussion, Limitations and food for thought

Appendix

Excerpt out of 49 pages

Details

Title: Do Pharmaceutical Mergers Harm Drug Innovation?
College: Utrecht University (Law, Economics and Governance)
Course: Mergers & Akquisitions
Grade: 8,5 (NL, äquivalent zu 1,2)
Author: Jan Schmidt (Author)
Year: 2013
Pages: 49
Catalog Number: V299729
ISBN (eBook): 9783656962168
ISBN (Book): 9783656962175
File size: 906 KB
Language: English
Keywords: pharmaceutical, mergers, harm, drug, innovation

Quote paper: Jan Schmidt (Author), 2013, Do Pharmaceutical Mergers Harm Drug Innovation?, Munich, GRIN Verlag, https://www.grin.com/document/299729

Comments